,allowExpansion;Resize,width=600)
Digital Pharma: Why your clear GS1 Digital Link strategy really matters
About this webinar
Join experts from Solidsoft Reply, GS1, and UNICEF TRVST as we explore how existing GS1 standards are enabling organisations to connect physical products with digital experiences for patients, healthcare professionals and supply chain partners.
Through industry insights, real-world case studies and practical implementation guidance, you'll learn how GS1 Digital Link is building on existing investments in serialisation and EMVS to support the next generation of connected healthcare.
Whether you're beginning to explore GS1 Digital Link or planning your adoption strategy, this webinar will help you understand both the strategic opportunity and the practical steps to get started.
What will you learn?
In this session, we'll cover:
-
Why healthcare is moving beyond identification and traceability
-
How One Product, One Barcode is transforming access to trusted digital information
-
Real-world insights from the UNICEF TRVST trial and early GS1 Digital Link adoption
-
How to build on existing investments such as serialisation and EMVS
-
Key considerations for data, governance, integration and implementation
-
Practical lessons for adopting GS1 Digital Link in regulated environments
This webinar is ideal for:
-
Pharmaceutical Manufacturing, Healthcare Organisations, Digital Transformation, Regulatory Affairs & Compliance, Serialisation & Traceability, Supply Chain, Product Information & Labelling,IT & Enterprise Architecture
Agenda
-
Welcome & Introduction: The evolution from product identification to digital engagement.
-
The Evolution of the Healthcare Barcode (GS1): One Product, One Barcode, GS1 Digital Link and the future of trusted digital product information.
-
From Concept to Reality: The TRVST Trial (UNICEF TRVST): A real-world implementation, lessons learned and future opportunities.
-
What Adoption Looks Like in Practice (Solidsoft Reply): Implementation considerations, governance, integrations and building on existing healthcare investments.
-
Panel Discussion & Live Q&A
Speakers
Traceability Lead
